Joris D. Veltman

952 total citations
21 papers, 732 citations indexed

About

Joris D. Veltman is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Immunology. According to data from OpenAlex, Joris D. Veltman has authored 21 papers receiving a total of 732 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 12 papers in Oncology and 5 papers in Immunology. Recurrent topics in Joris D. Veltman's work include Cancer Immunotherapy and Biomarkers (10 papers), Lung Cancer Treatments and Mutations (8 papers) and Occupational and environmental lung diseases (4 papers). Joris D. Veltman is often cited by papers focused on Cancer Immunotherapy and Biomarkers (10 papers), Lung Cancer Treatments and Mutations (8 papers) and Occupational and environmental lung diseases (4 papers). Joris D. Veltman collaborates with scholars based in Netherlands, Indonesia and United States. Joris D. Veltman's co-authors include Joachim G.J.V. Aerts, Joost P. Hegmans, Henk C. Hoogsteden, Rudi W. Hendriks, Margaretha Lambers, Menno van Nimwegen, Bart N. Lambrecht, Carl G. Figdor, I. Jolanda M. de Vries and Idris Bahce and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Journal of Respiratory and Critical Care Medicine and British Journal of Cancer.

In The Last Decade

Joris D. Veltman

20 papers receiving 722 citations

Peers

Joris D. Veltman

ONCOL

IMMUN

PRM

SURGE

Alistair Cook Australia

Morihiro Watanabe Japan

Mengxuan Yang China

C.R. Franks France

Céline Clémenson France

C.R. Franks United Kingdom

Francesca Scordamaglia Italy

Sara K. Daniel United States

Shozo Hojo Japan

Oldham Rk United States

Alistair Cook Australia

Joris D. Veltman

310 ×0.9

ONCOL

239 ×0.8

IMMUN

254 ×0.9

PRM

110 ×0.9

36 ×0.6

SURGE

Citations per year, relative to Joris D. Veltman Joris D. Veltman (= 1×) peers Alistair Cook

Countries citing papers authored by Joris D. Veltman

Since Specialization

Citations

This map shows the geographic impact of Joris D. Veltman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joris D. Veltman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joris D. Veltman more than expected).

Fields of papers citing papers by Joris D. Veltman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joris D. Veltman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joris D. Veltman. The network helps show where Joris D. Veltman may publish in the future.

Co-authorship network of co-authors of Joris D. Veltman

This figure shows the co-authorship network connecting the top 25 collaborators of Joris D. Veltman. A scholar is included among the top collaborators of Joris D. Veltman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joris D. Veltman. Joris D. Veltman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Silvis-Cividjian, Natalia, et al.. (2025). Bug Hunting Games to Add Enthusiasm in Software Testing and Programming Classes. VU Research Portal. 359–364.

Bahce, Idris, Chris Dickhoff, Famke L. Schneiders, et al.. (2024). Single-arm trial of neoadjuvant ipilimumab plus nivolumab with chemoradiotherapy in patients with resectable and borderline resectable lung cancer: the INCREASE study. Journal for ImmunoTherapy of Cancer. 12(9). e009799–e009799. 5 indexed citations

Hashemi, Sayed M.S., Ilias Houda, Joris D. Veltman, et al.. (2023). Predictive Value of Combined Positive Score and Tumor Proportion Score for Immunotherapy Response in Advanced NSCLC. JTO Clinical and Research Reports. 4(9). 100532–100532. 24 indexed citations

Heineman, David J., Famke L. Schneiders, Ilias Houda, et al.. (2023). OA06.04 Surgery after Neoadjuvant Immuno-Chemoradiotherapy in (Borderline) Resectable NSCLC: Results from the INCREASE Trial. Journal of Thoracic Oncology. 18(11). S56–S57. 4 indexed citations

Houda, Ilias, Sayed M.S. Hashemi, Johannes M. A. Daniels, et al.. (2023). 1445P A randomized phase III trial on Pembrolizumab Alone versUs pembrolizumab-chemotherapy in first LInE NSCLC (PAULIEN), results of the interim analysis. Annals of Oncology. 34. S821–S822. 1 indexed citations

Bahce, Idris, Famke L. Schneiders, Sayed M.S. Hashemi, et al.. (2022). 1020P Rescue by radiotherapy and anti-CTLA4/PD-1 after failure of anti-PD-1 therapy in metastatic NSCLC patients: The RECLAIM study. Annals of Oncology. 33. S1021–S1021. 1 indexed citations

Hashemi, Sayed M.S., Marieke F. Fransen, Anna-Larissa N. Niemeijer, et al.. (2021). Surprising impact of stromal TIL’s on immunotherapy efficacy in a real-world lung cancer study. Lung Cancer. 153. 81–89. 49 indexed citations

Hashemi, Sayed M.S., Jos W. R. Twisk, Ilias Houda, et al.. (2021). The effect of tumor size and metastatic extent on the efficacy of first line pembrolizumab monotherapy in patients with high PD-L1 expressing advanced NSCLC tumors. Lung Cancer. 162. 36–41. 6 indexed citations

Bach, Sander, Mark A. van de Wiel, Joris D. Veltman, et al.. (2021). Dynamics of methylated cell-free DNA in the urine of non-small cell lung cancer patients. Epigenetics. 17(10). 1057–1069. 9 indexed citations

10.

Bahce, Idris, Marieke F. Fransen, Joris D. Veltman, et al.. (2020). 1390P Impact of adding viagenpumatucel-L to nivolumab in non-small cell lung cancer (NSCLC) patients with low levels of tumour infiltrating lymphocytes. Annals of Oncology. 31. S883–S883. 1 indexed citations

11.

Dickhoff, Chris, Suresh Senan, Famke L. Schneiders, et al.. (2020). Ipilimumab plus nivolumab and chemoradiotherapy followed by surgery in patients with resectable and borderline resectable T3-4N0–1 non-small cell lung cancer: the INCREASE trial. BMC Cancer. 20(1). 764–764. 31 indexed citations

12.

Kos, Renate, Joris D. Veltman, Wilma Uyterlinde, et al.. (2020). Comparison of Myelotoxicity and Nephrotoxicity Between Daily Low-Dose Cisplatin With Concurrent Radiation and Cyclic High-Dose Cisplatin in Non-Small Cell Lung Cancer Patients. Frontiers in Pharmacology. 11. 975–975. 5 indexed citations

13.

Vijverberg, Susanne J. H., Elise M. A. Slob, Geoffrey Liu, et al.. (2018). Genetic Variations and Cisplatin Nephrotoxicity: A Systematic Review. Frontiers in Pharmacology. 9. 1111–1111. 42 indexed citations

14.

Veltman, Joris D., et al.. (2018). Total electrical alternans in a patient with malignant pericardial tamponade. BMJ Case Reports. 2018. bcr–2018. 2 indexed citations

15.

Aerts, Joachim G.J.V., Joost P. Hegmans, Joris D. Veltman, et al.. (2012). History of tuberculosis as an independent prognostic factor for lung cancer survival. Lung Cancer. 76(3). 452–456. 26 indexed citations

16.

Hegmans, Joost P., Joris D. Veltman, Margaretha Lambers, et al.. (2010). Consolidative Dendritic Cell-based Immunotherapy Elicits Cytotoxicity against Malignant Mesothelioma. American Journal of Respiratory and Critical Care Medicine. 181(12). 1383–1390. 120 indexed citations

17.

Veltman, Joris D., Margaretha Lambers, Menno van Nimwegen, et al.. (2010). Zoledronic acid impairs myeloid differentiation to tumour-associated macrophages in mesothelioma. British Journal of Cancer. 103(5). 629–641. 87 indexed citations

18.

Veltman, Joris D., Margaretha Lambers, Menno van Nimwegen, et al.. (2010). Low-Dose Cyclophosphamide Synergizes with Dendritic Cell-Based Immunotherapy in Antitumor Activity. SHILAP Revista de lepidopterología. 2010. 1–10. 31 indexed citations

19.

Hegmans, Joost P., Joris D. Veltman, Eric T. Fung, et al.. (2009). Protein Profiling of Pleural Effusions to Identify Malignant Pleural Mesothelioma Using SELDI-TOF MS. Technology in Cancer Research & Treatment. 8(5). 323–332. 23 indexed citations

20.

Cools, Martine, Friedemann Honecker, Hans Stoop, et al.. (2005). Maturation delay of germ cells in fetuses with trisomy 21 results in increased risk for the development of testicular germ cell tumors. Human Pathology. 37(1). 101–111. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact